Detalhe da pesquisa
1.
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer.
Gynecol Oncol
; 182: 124-131, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262235
2.
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer.
Cancer
; 129(5): 740-749, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517940
3.
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer.
Oncologist
; 28(7): e498-e507, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023705
4.
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer.
Cancer Immunol Immunother
; 72(9): 3013-3027, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294342
5.
Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.
Ann Surg Oncol
; 30(12): 7814-7824, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37501051
6.
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer.
Oncologist
; 26(2): 99-e217, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33141975
7.
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer.
Oncologist
; 26(3): e382-e393, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098195
8.
ASO Visual Abstract: Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the United States.
Ann Surg Oncol
; 30(12): 7869-7870, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37598124
9.
Explicit underdose control based on toxicity: Four points to consider.
Stat Med
; 41(27): 5491-5493, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36394105
10.
New Approaches for Immune Directed Treatment for Ovarian Cancer.
Curr Treat Options Oncol
; 17(3): 14, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26942589
11.
Validation and feasibility of a caloric expenditure measuring device in women with early-stage breast cancer.
Support Care Cancer
; 22(9): 2329-36, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25082619
12.
Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data.
Contemp Clin Trials
; 125: 107083, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638911
13.
First-In-Human Pilot PET Immunoimaging Study of 64Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers.
Cancer Biother Radiopharm
; 38(1): 26-37, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36154291
14.
Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma.
Biol Blood Marrow Transplant
; 18(3): 486-92, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22198542
15.
A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial.
Invest New Drugs
; 30(2): 741-8, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20967484
16.
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer.
Cancers (Basel)
; 14(13)2022 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804935
17.
Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study.
J Nucl Med
; 63(8): 1145-1148, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34857660
18.
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer.
Cancers (Basel)
; 14(17)2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077811
19.
Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and design.
Pleura Peritoneum
; 7(4): 169-177, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36560966
20.
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants.
iScience
; 25(8): 104745, 2022 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846380